Costa Group Holdings Limited Downgraded its Earning Guidance

An agricultural business, Costa Group Holdings Limited (ASX: CGC) has updated its earnings guidance today. The company now expects its full calendar year results to be lower than its previous expectations.

In the last six months, the company has experienced an unprecedented level of volatility across all of its categories. The earnings for the six months are going to be significantly lower than the prior comparable six-month period due to the number of factors, including the consolidation of the company’s majority ownership stake in African Blue and additional pre-harvest farming cost investment through its increased international footprint in Morocco and China. December saw subdued trading, mainly in the company’s berry, avocado and tomato categories, which affected the company’s earnings.

Further, the earnings for the half-year period were also affected due to the biennial nature of its citrus crop, with 2018 being an ‘off year’ and also a shorter season than 2017.

As a consequence of above-mentioned factors, the company’s net profit after tax minus SGARA (NPAT-S) earnings were below plan by around $3.5 million. CGC’s revenue for the six months period was down 2.4% on the previous corresponding period. EBITDA before SGARA, material items and amortisation (EBITDA-S) was $35.3 million, down 42.0% on the prior period.

Financial Performance (Source: Company Reports)

According to the updated guidance, the company is now expecting its CY19 EBITDA-SL to be in the range of $140 million to $153 million and its NPAT-SL to be between $57 million to $66 million.

While addressing the shareholders in today’s Annual General Meeting, the company’s CEO has advised that the Costa Group is committed to achieving an average annual low double-digit earnings growth trajectory with a planning framework centred on a rolling three to five-year time frame.

Currently, the Board is intensely focused on ensuring that the long term fundamentals continue to be strengthened and the company retains its competitive advantage in the face of any future trading volatility.

The company’s berry growth program has been focused on building its capacity to grow blueberries and raspberries for 52 weeks of the year.

The company’s international operations encompassing Morocco and China are growing continuously. CGC’s Morocco 2018/19 expansion program has focused on further early season planting in Agadir, which is approximately 720kms south of the company’s established plantings in the north. In China, CGC’s total plantings at the end of December 2018 were 110 hectares, with a further 65 hectares of blueberries completed in May 2019, with a similar area to be planted in 2020. Overall, the company is tracking to its initial five-year China plan.

At market close on 30th May 2019, the stock of the company was trading at a price of $3.760, down by 27.413% during the day’s trade with a market capitalisation of $1.66 billion.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report